• Text Resize A A A
  • Print Print
  • Share Share Share Share

Forty-Third ACBTSA Meeting: June 5-6, 2013

June 5, 2013 - June 6, 2013

NIH Conference Room
5635 Fisher’s Lane, Terrace Level
Rockville, MD

Agenda

Wednesday, June 5, 2013

Time Agenda Item Presenter
07:30
(30 min)
Doors Open Open to the Public
08:00
(5 min)
Call to Order Jay Menitove, MD
Committee Chair
08:05
(10 min)
Roll Call James Berger
Executive Secretary

Committee Business

Time Agenda Item Presenter
08:15
(10 min)
New Members Welcome Howard K. Koh, MD, MPH
HHS Assistant Secretary for Health
08:25
(20 min)
Assistant Secretary for Health’s Charge to the Committee Howard K. Koh, MD, MPH
HHS Assistant Secretary for Health

Committee, Subcommittee & Workshop Updates

Time Agenda Item Presenter
08:45
(10 min)
Advisory Committee on Organ Transplantation (ACOT) Update Mark Barr, MD
Chair, Advisory Committee on Organ Transplantation, HHS / HRSA
08:55
(10 min)
Transmissible Spongiform Encephalopathies Advisory Committee (TSEAC) Update
  • FDA risk assessment of vCJD risk for transfusions of Red Blood Cells in the U.S.
Hong Yang, PhD
HHS/ FDA/CBER/OBE
09:05
(10 min)
Blood Products Advisory Committee (BPAC) Update
  • December Meeting, Organ donor infectious disease screening
Laura St. Martin, MD, MPH
HHS/FDA/CBER/OCTGT
09:15
(10 min)
FDA Workshop on Advances in Nucleic Acid and Protein Bases Multiplex Detection Methods to Improve Transfusion Safety Sanjai Kumar, PhD
HHS/FDA/CBER/OBRR
09:25
(5 min)
MSM Study Update and Timeline James Berger
Executive Secretary
09:30
(5 min)
Public Health Service Guidelines Update
  • 2013 Public Health Service (PHS) Guideline for Reducing Transmission of HIV, HBV, and HCV through Solid Organ Transplantation
Matthew Kuehnert, MD
Director, Office of Blood, Organ, & Other Tissues Safety
HHS / CDC / OID / NCEZID
09:35
(10 min)
Subcommittee Update: Informed Consent in Transfusions and Transplantation Jim Bowman, MD
Medical Director
Division of Transplantation
HHS/HRSA
09:45
(15 min)
Subcommittee Update: Blood Safety and Availability in Emergencies Aryeh Shander, MD
Chief, Department of Anesthesiology, Critical Care Medicine, Hyperbaric Medicine & Pain Management
Englewood Hospital & Medical Center
Clinical Professor of Anesthesiology, Medicine & Surgery
Mount Sinai School of Medicine
10:00
(15 min)
Subcommittee Update: Tissue Safety and Availability in Emergencies Tim Pruett, MD
Chief, Division of Transplantation University of Minnesota
10:15 Break • 10 min  

Committee Topic: Is the Current Blood Center System in the U.S. Designed for Optimal Service Delivery in the Era of Health Care Reform

Time Agenda Item Presenter
10:25
(40 min)
Trends in Blood Collection and Utilization: Results from the 2011 National Blood Collection & Utilization Survey Barbee Whitaker, PhD
Director, Center for Data and Special Programs
AABB
11:05
(40 min)
Perspectives from AABB Karen Shoos, JD
Principal Investigator,
International Technical Assistance
AABB
11:45
(40 min)
Perspectives from America’s Blood Centers David Green, MSA
CEO, Mississippi Valley Regional Blood Center
ABC President
12:25 Lunch Break • 45 min  
01:10
(40 min)
Perspectives from the Plasma Protein Therapeutics Association Bill Speir, JD
PPTA Director, State Affairs
01:50
(40 min)
Insuring a Successful Future for America’s Blood Centers Mark Popovsky, MD
Vice President and Chief Medical Officer Haemonetics
02:30 Break • 10 min  
02:40
(40 min)
Pathway to the Future – Pluralistic and Innovative Models for Blood Centers Jackie Fredrick
President & CEO,
Centers for Transfusion and Transplant Medicine,
Blood Center of Wisconsin I
03:20
(25 min)
Potential Impact of Pathogen Inactivation: A Hospital and Clinician Perspective S. Gerald Sandler, MD, FACP, FCAP
Georgetown University Hospital
03:45
(40 min)
Perspectives from a Blood and Tissue Center Linda Myers
CEO South Texas Blood & Tissue Center
President/COO of QualTex Laboratories
04:25 Adjournment Committee Chair

Thursday, June 6, 2013

Time Agenda Item Presenter
07:30
(30 min)
Doors Open Open to the Public
08:00
(5 min)
Call to Order Jay Menitove, MD
Committee Chair
08:05
(10 min)
Roll Call James Berger
Executive Secretary
08:15
(40 min)
Blood Center Sustainability: Knowing the Customer Jim AuBuchon, MD
President & CEO
Puget Sound Blood Center
08:55
(30 min)
Hospital Perspective Joe Rutledge, MD
Medical Director, Laboratories
Seattle Children’s Hospital
09:25
(40 min)
Changes in Transfusion Demand Richard Benjamin, MD, PhD, FRCPath
Chief Medical Officer, Biomedical Services
American Red Cross
10:05 Break • 10 min  
10:15
(40 min)
Perspectives from the American Red Cross Chris Hrouda
Executive Vice President
American Red Cross
10:55
(40 min)
Interpreting the Affordable Care Acts impact on the Blood Community Theresa Weigmann, JD
Director, Public Policy and Special Counsel
AABB
11:35
(35 min)
Thoughts on Present and Future Drivers of the Demand for Blood Products in a Reforming U.S. Health Care System David O. Meltzer, MD, PhD
Chief, Section of Hospital Medicine;
Associated Faculty Member, the Harris School and the Department of Economics,
the University of Chicago
12:10 Lunch Break • 45 min  
12:55
(15 min)
Open Public Hearing (all sessions/considerations)  
01:10
(2 hr)
Committee Discussion for Committee Questions & Recommendations  
03:10 Adjournment Jay Menitove, MD
Committee Chair
Back to Top